The joys of in vitro selection: chemically dressing oligonucleotides to satiate protein targets

https://doi.org/10.1016/S1367-5931(97)80103-2Get rights and content

Abstract

Oligonucleotide in vitro selection provides surprisingly specific aptamers to protein targets. Synthetic chemistries for modifying nucleotides have been developed to enhance aptamer binding affinity. The diversity of nucleosides amenable to either triphosphate synthesis or phosphoramidite activation is now sufficiently broad to rival any oligomeric combinatorial library.

References (65)

  • B Levitan et al.

    Adaptive walks with noisy fitness measurements

    Mol Divers

    (1995)
  • L Gold et al.

    Diversity of oligonucleotide functions

    Annu Rev Biochem

    (1995)
  • KW Uphoff et al.

    In vitro selection of aptamers: the dearth of pure reason

    Curr Biol

    (1996)
  • L Gold

    Oligonucleotides as research, diagnostic, and therapeutic agents

    J Biol Chem

    (1995)
  • JR Lorsch et al.

    Chance and necessity in the selection of nucleic acid catalysts

    Accounts Chem Res

    (1996)
  • PA Lohse et al.

    Ribozyme-catalysed amino-acid transfer reactions

    Nature

    (1996)
  • M Illangasekare et al.

    Aminoacyl-RNA synthesis catalyzed by an RNA

    Science

    (1995)
  • J Tsang et al.

    Specialization of the DNA-cleaving activity of a Group I ribozyme through in vitro evolution

    J Mol Biol

    (1996)
  • C Wilson et al.

    In vitro evolution of a self-alkylating ribozyme

    Nature

    (1995)
  • M Wecker et al.

    In vitro selection of a novel catalytic RNA: characterization of a sulfur alkylation reaction and interaction with a small peptide

    RNA

    (1996)
  • EH Ekland et al.

    Structurally complex and highly active RNA ligases derived from random RNA sequences

    Science

    (1995)
  • B Cuenoud et al.

    A DNA metalloenzyme with DNA ligase activity

    Nature

    (1995)
  • P Burgstaller et al.

    Synthetic ribozymes and the first deoxyribozyme

    Angew Chem I Int Ed

    (1995)
  • R Rohatgi et al.

    Kinetic and mechanistic analysis of nonenzymatic, template-directed oligonucleotide ligation

    J Am Chem Soc

    (1996)
  • EH Ekland et al.

    RNA-catalyzed RNA polymerization using nucleoside triphosphates

    Nature

    (1996)
  • R Rohatgi et al.

    Nonenzymatic, template-directed ligation of oligonucleotides is a highly regioselective for the formation of 3′→5′ phosphosphodiester bonds

    J Am Chem Soc

    (1996)
  • Y Wang et al.

    RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities

    Biochemistry

    (1996)
  • MG Wallis et al.

    A novel RNA motif for neomycin recognition

    Chem Biol

    (1995)
  • Y Wang et al.

    Specific binding of aminoglycoside antibiotics to RNA

    Chem Biol

    (1995)
  • P Burgstaller et al.

    Structural probing and damage selection of citrulline- and arginine-specific RNA aptamers identify base positions required for binding

    Nucleic Acids Res

    (1995)
  • DE Huizenga et al.

    A DNA aptamer that binds adenosine and ATP

    Biochemistry

    (1995)
  • CT Lauhon et al.

    RNA aptamers that bind flavin and nicotinamide redox cofactors

    J Am Chem Soc

    (1995)
  • Cited by (98)

    • An efficient method to evaluate experimental factor influence on in vitro binding of aptamers

      2018, Analytical Biochemistry
      Citation Excerpt :

      The binding step is also critical to minimize the nonspecific binding in the selected pool. Numerous factors can have an impact on the nonspecific binding, such as the properties of the aptamers (including nucleic acid type, length, base composition and modification) [37–39], the target, as well as the experimental factors (including ionic strength, buffering agent, temperature, pH, and so on) [40]. The situation is even more complicated when the aptamer selection is performed in complex matrix, for example, buffer containing a cocktail of proteins and other metabolites similar to the condition under which the aptamer would be expected to work in.

    • Biophysics and protein corona analysis of Janus cyclodextrin-DNA nanocomplexes. Efficient cellular transfection on cancer cells

      2017, Biochimica et Biophysica Acta - General Subjects
      Citation Excerpt :

      However, in the case of biomolecular drugs, such as nucleic acids, the carrier becomes a decisive protagonist. In the free state, nucleic acids are easily degraded by nucleases in biological fluids [13,14], and their membrane-crossing abilities and cellular uptake are seriously limited by their negative charge, inherently large size, and rigidity [15]. Formulation with appropriate delivery systems is thus essential for nucleic acids to overcome the physiological barriers, reach the target in a fully functional form and carry out the designed therapeutic function.

    • FDA-Approved Oligonucleotide Therapies in 2017

      2017, Molecular Therapy
      Citation Excerpt :

      Macugen (formerly pegaptanib) is an aptamer targeted to vascular endothelial growth factor (VEGF165). The molecule was first produced by the systematic evolution of ligands by exponential enrichment (SELEX)2,3 strategy pioneered by Larry Gold (an excellent review by Ng et al.4 provides a brief, concise description of the SELEX approach). Pegaptanib is 27 nucleobases in length.

    • Imidazole-free purification of His<inf>3</inf>-tagged recombinant proteins using ssDNA aptamer-based affinity chromatography

      2015, Journal of Chromatography A
      Citation Excerpt :

      The aptamers may have a wide range of applications, including molecular biology, biotechnology and medicine [19]. In the last 20 years, many examples of aptamers developed against different targets, including proteins and even cells have been reported [20–23]. The dynamic development of research on ssDNA aptamers is stimulated by their features, e.g. binding strength comparable to antibodies [24], low immunogenicity [23], the simple, fast and relatively cheap synthesis.

    View all citing articles on Scopus
    View full text